{
    "url_original": "https://www.wsj.com/articles/23andme-earmarks-cash-from-spac-deal-for-drug-development-11638305638?mod=business_minor_pos13",
    "url": "23andme-earmarks-cash-from-spac-deal-for-drug-development-11638305638",
    "title": "23andMe Earmarks Cash from SPAC Deal for Drug Development",
    "sub_head": "The company known for its at-home ancestry tests is developing two drugs to treat cancer",
    "category_1": "CFO Journal",
    "image_1_url": "https://images.wsj.net/im-443456?width=860&height=573",
    "image_1": "im-443456.jpg",
    "time": "2021-11-30 15:53:00"
}